Life Science Talent Talks

Life Science Talent Ecosystem
  • 0.0 (0)
  • Entrepreneurship
  • Updated weekly

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. 𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺: Take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our community page: https://www.linkedin.com/groups/12717528/ Follow us: Nehar: https://www.linkedin.com/in/neharmortuza/ and Søren: https://www.linkedin.com/in/soren-spanner-bach/

  1. 3 days ago

    E72 #Ecosystem Builders “From Lab to Value Chain: Mission-Driven Carbon Capture” with CORC's Lasse Rosendahl & Alexia Jacobsen

    In this podcast episode on turning research into societal value, host Søren Spanner Bach is joined by co-host Per Christensen of Black Swans Exist and guests Lasse Rosendahl, Director of CORC, and Alexia Jacobsen, Head of Innovation at CORC - the Novo Nordisk Foundation CO2 Research Center, headquartered in Aarhus with partner institutions across Europe and the US. The conversation centres on a deceptively simple question: what does it actually take to translate CO2 research into real-world impact when the value chain you need doesn't yet exist? Lasse and Alexia walk through the full journey - from TRL 1 microbe experiments exploring how to transform CO2 into methane, to a 200x scale-up pilot facility at Campus Viborg that is already testing market viability by exploring the sale of carbon credits and offtake products at pilot scale. A key theme throughout is that the TRL ladder is not linear: scaling up consistently surfaces new fundamental questions, sending research back down before moving forward again. Iteration is the design, not the exception. The bottleneck in commercializing carbon utilization is less about technology maturity and more about the near-complete absence of governmental verification frameworks for CCU and CCC in Europe - and the missing value chains that spin-outs need to survive. Alexia also introduces CORC's approach to impact measurement: rather than imposing performance indicators that produce what you measure rather than what you want, the team is developing key value measures in direct dialogue with researchers. And critically, the innovation team's role is to remove the administrative and legal obstacles from the researcher's path - so that scientists can stay focused on the science while still contributing to real-world impact. ⏱️ TIMESTAMPS 01:26 What Is CORC? — Mission, Funding and International Scope 04:11 Why CO₂ Research Matters — And What TRL Actually Means 06:45 TRL in Practice — From Lab-Scale Microbes to Pilot Reactors 10:42 The Real Bottleneck — Value Chains That Don’t Exist Yet 17:13 What Can Industry Do? — Spin-Ins, De-Risking and Ecosystem Building 21:57 Researcher KPIs vs Real-World Impact — How to Navigate Both 25:20 CORC’s Four Mission Streams — Interdisciplinary Design 29:01 Keeping Researchers Mission-Aligned — Annual Meetings and Shared Direction 35:00 What Europe Can Learn from the US — Entrepreneurship and Failure Culture 38:21 Coalition on Advancing Research Assessment — Rethinking Researcher Metrics 41:46 Selling Credits at Pilot Scale — Testing the Market Before It Exists 43:15 Excel ERIC — Sharing Infrastructure Across Europe 45:29 Why Aarhus? — Location, Ecosystem and Production Pipeline 46:41 Impact by 2028 — Technologies Out, Value Chains Built, Knowledge Compounded 50:14 Target Industries and Products — What CORC Is Looking For 💡 QUOTES "If we are not successful in bringing down atmospheric CO2 levels, it will have consequences — not for the planet, which will survive — but for the way we as humans inhabit the Earth." — Lasse "If the value chain is not there, we set spin-outs up to fail. That's essentially what we're doing." — Alexia Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    E72 #Ecosystem Builders “From Lab to Value Chain: Mission-Driven Carbon Capture” with CORC's Lasse Rosendahl & Alexia Jacobsen

  2. 13 Aug

    E71 #Ecosystem Builders "From Spin-Outs to Spin-Ins: How Incuba Shapes Aarhus' Innovation Ecosystem" with Jacob Doktor Mogensen

    Jacob Doktor Mogensen, CEO of Incuba, joins the show to unpack how Aarhus's science park model turns university research into scaled companies. The conversation moves from Incuba's problem-first, hands-on approach to acceleration, through real cases like Coana and CrowdStrike/Humio, to the harder question of why Danish companies sell out to international capital - and what "spinning in" corporate innovation could change. Listeners get a grounded look at what actually moves a startup from idea to exit. Episode Timestamps (09:37) Concrete support: financing, applications, introductions (10:49) The Investor Hub: proximity that closes deals (27:26) Success story: Quana's journey and US sale (41:39) Defining "spin-in" innovation (46:14) Spin-in success story: CrowdStrike and Humio (50:01) Turning company problems into student projects (55:00) Aarhus' innovation ecosystem over the next 10 years Guest Bio Jacob Doktor Mogensen is CEO of Incuba, the Aarhus-based science park connecting university spin-outs, established companies, and investors across three hubs. Before Incuba, he spent fifteen years in Danish innovation clusters and science parks, including time in the food industry. Resources Mentioned Incuba (Incuba.dk) — science park hubs at Katrinebjerg, Navitas, and Skejby Incuba on LinkedIn Coana — Aarhus University spin-out and EU Horizon-funded case study CrowdStrike / Humio acquisition Delfinus Venture Capital InnoFonden, InnoBooster, Horizon Europe funding programs Startup Aarhus Aarhus Investor Summit (October 8) Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉)

    E71 #Ecosystem Builders "From Spin-Outs to Spin-Ins: How Incuba Shapes Aarhus' Innovation Ecosystem" with Jacob Doktor Mogensen

  3. 6 Aug

    E70 #Ecosystem Builders “Center for Biosolutions: DTU Vision and Pathways” with Andreas Worberg

    In this podcast episode on turning fragmented world-class research into a connected biosolutions ecosystem, host Søren Spanner Bach is joined by guest Andreas Worberg, the driving force behind the new Center for Biosolutions at DTU (Technical University of Denmark) - a cross-departmental initiative uniting eight departments and close to 2,000 researchers under DTU's non-medical biotechnology efforts. Andreas shares candid reflections on why DTU, despite ranking as Europe's best engineering university and fifth in the world for biotech, has struggled to make that strength visible and legible to industry, policymakers, and the public - and what the new center is doing to fix it. Key structural challenges discussed include the internal fragmentation of a large polytechnical university where departments rarely know what their neighbours are working on, a publication-driven incentive structure that pushes researchers toward papers over spin-outs, and years of specialised equipment sitting underused in campus vaults due to legal and liability hurdles around sharing it. Andreas also reflects on the trust-building work required to make collaboration feel like an opportunity rather than a threat to a researcher's own career and turf. Andreas draws a striking comparison to the arrival of ChatGPT, arguing biotechnology is nearing its own inflection point as AI, quantum computing, and biotech converge - and cautions that businesses investing heavily in AI and quantum while overlooking biotech may be missing where the next wave of disruption actually lands. His closing message: DTU has been playing the long game in biosolutions for years, and now, with a center to make that work visible, Denmark's biosolutions ecosystem is ready to be discovered. ⏱️ TIMESTAMPS 04:26 Why Biology Is the Next Manufacturing Platform 10:11 Why Commercialization Boosts a Researcher's Academic Footprint 28:06 Closing the Non-Medical Biotech Innovation Gap 32:57 Papers vs. Spin-Outs: You Get What You Measure 34:28 The Biosustain Lesson: Freedom Breeds Entrepreneurs 53:00 The Innovation Pillar: Learning From MIT's Playbook 57:06 Student-Driven Startups vs. Top-Down Innovation 💡 QUOTES "Large diverse universities... have the challenge that often the right hand does not necessarily know what the left hand is doing." — Andreas Links: https://biosolutions.dtu.dk/ Guest Bio Andreas trained as a biologist, with a doctorate in Germany spanning botany and molecular biology. He spent ten years at a large German engineering company, where he helped design, build, and operate large-scale biochemical plants as its first biologist. He joined DTU in 2017, spending eight years at DTU Biosustain, and today also connects non-medical biotech to defense applications through NATO. Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes.

    E70 #Ecosystem Builders “Center for Biosolutions: DTU Vision and Pathways” with Andreas Worberg

  4. 25 Jun

    E69 #Ecosystem Builders "Denmark's Biotech Potential: Innovation Gaps, Capital Challenges & National Frameworks" with Morten Engsbye

    In this podcast episode on turning research into societal value, host Søren Spanner Bach is joined by co-host Per Christensen of Black Swans Exist and guest Morten Engsbye, CEO of Danish BIO (Dansk Biotek) - the industry association representing over 190 pharmaceutical and industrial biotech companies in Denmark. Morten shares candid reflections on why Denmark, despite being Europe's #2 nation for per-capita life sciences publications, consistently underperforms at translating that world-class research into new companies - and what it will take to fix it. Key structural challenges discussed include the cultural gap between academic excellence and entrepreneurial ambition, the scarcity of early-stage capital as late-stage companies attract the lion's share of investment, and Denmark's 42% capital gains tax making biotech investment unattractive compared to property or neighbouring Sweden. In a world premiere, Morten also unveils Danish BIO's proposal for direct cash grants to university departments that successfully spin out companies - a mechanism designed to make innovation a leadership priority at department level, not just an individual pursuit. Morten also sounds the alarm on Denmark's GDP dependency on a small number of blockbuster drugs - life sciences now accounts for approximately 60% of all Danish GDP growth - and makes a compelling case for unlocking the country's 4.5 trillion DKK in pension fund assets, currently investing just 0.018% into venture compared to 1.9% in the US. His closing message: Denmark is a life sciences nation in every metric that matters. It just hasn't realised it yet. TIMESTAMP 00:00 Morten Engsbye and Danish BIO 02:00 The Translation Gap: World-Class Research, Not Enough Companies 03:00 Why Other Countries Are Better at Spinning Out Science 06:00 World Premiere: Danish BIO's Department-Level Spin-Out Incentive Proposal 09:00 Freedom vs Mandates: Why Incentives Beat Obligations 11:00 Genmab, Myelomatosis & What Biotech Success Really Looks Like 13:00 The GDP Time Bomb: When Patents Expire, Markets Collapse 17:00 The Capital Crisis: $2.1 Billion to Bring a Drug to Market 19:00 A Schizophrenic Capital Market: Late-Stage Flush, Early-Stage Starved 20:00 Where Should the Capital Come From? The Draghi & Letta Reports 21:00 Capital Gains Tax: 42% in Denmark vs 27% in Sweden 23:00 Pension Funds: 4.5 Trillion DKK Doing Very Little for Denmark 24:00 The 100x Gap: US vs European Pension Funds in Venture 26:00 Ferrari vs Denmark: One Fund's Investment Priorities 29:00 Forcing vs Incentivising Pension Funds: The Italian Model 30:00 Why It Should Be a Slam Dunk — Jobs, Patients, Returns 34:00 Denmark as a Life Sciences Nation — and Why Politicians Don't See It 36:00 Call to Action for Academics and Department Leaders 40:00 Brain Drain: How Danish Taxpayer-Funded Research Ends Up in Boston Quote: "We pay for the research. They build the company here. Then, because there's no capital market, they leave for Boston — pay their taxes there, create all the jobs there. And we sit back holding the bill." — Morten Engsbye Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    E69 #Ecosystem Builders "Denmark's Biotech Potential: Innovation Gaps, Capital Challenges & National Frameworks" with Morten Engsbye

  5. 18 Jun

    E68 #Ecosystem Builders "Turning Great Science into Green Impact: BRIGHT’s Mission, Model, and European Playbook” with Luuk van der Wielen

    In this episode, Luuk van der Wielen, Head of BRIGHT (Novo Nordisk Foundation Biotechnology Research Institute for the Green Transition), joins Søren Spanner Bach and Per Christensen from Black Swans Exist in collaboration with Life Science Talent Talks to unpack what it will take for Europe to turn biotech innovation into real, sustainable economic value. Luuk introduces BRIGHT's core mission: helping Europe reduce emissions, strengthen resource autonomy, and build a more resilient industrial base - not through isolated breakthroughs, but through the kind of system-level change that reshapes technology, supply chains, regulation, incentives, and social behavior all at once. The conversation draws on powerful historical precedents - Brazil's Proálcool biofuel program and Denmark's biogas infrastructure - to illustrate why lasting green transitions are never built on a single "silver bullet" product, but on coordinated, long-term ecosystem thinking. Luuk also shares how BRIGHT itself is evolving: moving beyond its Biosustain roots and a science-and-startup model toward more open public-private collaboration, scenario-based "reverse design" roadmaps anchored in 2050 goals, and impact-focused KPIs that go well beyond publications and patents. The episode explores BRIGHT's three strategic focus areas - sustainable materials, microbial and sustainable foods, and zero-emission agriculture - and what it means to build research infrastructure that is measured by real-world outcomes. Finally, Luuk issues a direct invitation to potential partners and makes a compelling case for deeper European collaboration and a fairer, continent-wide level playing field for biotech innovation. ⏱️ TIMESTAMP 00:00 Series Kickoff 00:36 Meet Pierre and Black Swans 01:13 Luuk’s Career Journey 04:03 What BRIGHT Does 06:28 Innovation for Green Transition 06:51 Brazil’s Biofuel Lesson 08:52 Systems Change Not Silver Bullets 10:20 BRIGHT’s Origin Story 11:56 From Startups to Partnerships 13:22 Biogas to High Value Proteins 16:04 Key Ingredients for Collaboration 17:42 Sustainable Innovation Office 18:22 Reverse Designing the Roadmap 20:28 Scenario Planning and Outreach 21:37 Tech Plus Policy and Society 22:33 Policy Targets and Autonomy 24:02 Biogas Infrastructure Strategy 26:40 Future Scenarios and Innovations 30:00 Impact Metrics in Academia 34:47 Europe Collaboration and Equity 38:03 Ecosystem Gaps and Level Playing Field 39:48 Bright Partnerships and Missions 💡 Quote: "Innovation is important in the systems change, but also the regulatory system, the financial system. You don't solve it with one super plastic that comes from BioSolutions. You have to look at the total systems change." - Luuk van der Wielen Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    E68 #Ecosystem Builders "Turning Great Science into Green Impact: BRIGHT’s Mission, Model, and European Playbook” with Luuk van der Wielen

  6. 12 Jun

    E67 #Ecosystem Builders "Scaling Health Tech: Funding, Traction & Faster EU Approval" with Jesper Grønbæk

    In this podcast episode on turning research into societal value, host Søren is joined by co-host Per Christensen of Black Swans Exist and guest Jesper Grønbæk, CEO and founder of the nonprofit Health Tech Hub Copenhagen (supported by the Danish Industry Foundation and the Novo Nordisk Foundation). Jesper shares key learnings from supporting 100+ health tech startups and scale-ups, as well as collaborating with hospitals, pharma, insurers, and a 200+ investor network - including enabling hospital “speed-dating” access in markets like Germany. Key pitfalls discussed include solving “nice-to-have” problems instead of top-priority hospital needs, failing to secure an influential key opinion leader early, starting fundraising too late while overlooking non-dilutive “soft money” grants, and lacking commercial traction due to staying overly project-focused. He emphasizes the importance of early investor relationship-building, being selective with investors, and maintaining a strong commercial focus - sometimes even launching below MDR/CE-mark requirements first. Jesper also introduces the upcoming Health Tech Pathways platform, which uses expert-trained AI to guide EU MDR medical device regulation and improve documentation quality - ultimately reducing the time and cost associated with today’s multi-year EU processes. TIMESTAMP 00:42 Meet Health Tech Hub 01:47 Ecosystem Connections 02:47 Hospital Access Speed Dating 03:50 Why Jesper Started 05:42 Healthcare Pressure Ahead 06:23 Mistake One Nice to Have 08:43 Key Opinion Leaders 10:12 Mistake Two Fundraising 10:53 Soft Money and Accelerators 12:14 Choosing Investors Wisely 14:48 Mistake Three Commercial Traction 16:42 Traction Under Regulation 18:18 Consumers Paying for Health Apps 19:14 Who Pays for Health Tech 19:56 Building Health Tech Pathways 21:27 MDR Explained and Risk Classes 22:38 Why EU Approval Takes Longer 23:50 Ideal Users and Early Strategy 24:32 Plain English Plus Compliance 26:56 AI Powered Regulatory Guidance 27:38 Cutting Time with Better Docs 28:31 Ecosystem Wishlist Reimbursement 30:33 Community Call to Collaborate 31:30 Denmark Strengths and Next Steps Quote: "Finding a co-founder is like finding a spouse — it's somebody you want to work with for a very long time in a harsh environment." — Jesper Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    E67 #Ecosystem Builders "Scaling Health Tech: Funding, Traction & Faster EU Approval" with Jesper Grønbæk

  7. 3 Jun

    E66 #Ecosystem Builders "From excellent research to real-world impact" with Jens Nielsen

    In this episode, Jens Nielsen, CEO of BioInnovation Institute, joins Søren and Per Christensen from Black Swans Exist to share how Denmark built one of the world’s leading life science startup ecosystems - and how that model is now being expanded into quantum and deep tech. Jens reflects on his journey from academic researcher and professor in engineering biology to serial entrepreneur and ecosystem builder. He discusses how his passion for translating science into real-world impact led him to found multiple companies and eventually help build BII as a launchpad for early-stage innovation. The conversation explores how ecosystems are formed, what makes academic science commercially viable, and why the combination of talent, capital, and institutional support is critical. Jens also explains why Denmark has been uniquely successful in scaling biotech startups and what lessons can be transferred to emerging fields like quantum technology. A central theme is how scientists can transition into entrepreneurship - not just through training, but through mindset shifts, feedback culture, and selecting the right people with coachability, curiosity, and resilience. The episode also dives into team dynamics, founder evolution, and why most startup challenges ultimately come down to people rather than technology. Finally, Jens shares a broader reflection on Europe’s opportunity in deep tech and why researchers must take responsibility for translating their own work into societal impact. ⏱️ TIMESTAMP 00:00 Introduction – Life Science Talent Talks Miniseries & Ecosystem Builders 01:00 Jens Nielsen’s Background - Engineering Biology, Academia & Entrepreneurship 03:00 The Birth of BioInnovation Institute (BII) 06:00 Why Denmark Became a Life Science Startup Leader 07:00 From Life Science to Quantum Ecosystems 12:00 Ingredients of a Strong Deep Tech Ecosystem 21:00 Selecting Scientific Entrepreneurs - Science + Market Fit 30:00 Rethinking Startup Education - From Lectures to Gap Analysis 32:00 Mindset of Scientific Entrepreneurs 35:00 Founder-to-CEO Evolution in Scaling Companies 39:00 Cap Tables, Equity & Managing Founder Expectations 41:00 Investor Dynamics & Founder Role Transitions 44:00 Culture, Leadership Principles & Scaling Challenges 48:00 Academic Training as Entrepreneurial Advantage 50:00 Europe vs US in Deep Tech Innovation 💡 Quote: “You cannot find a better entrepreneur to translate science than the person who actually did the science - because they know it deeply and care about making it matter.” - Jens Nielsen Ideas for future podcast guests or themes? 💡 We want to co-create this podcast with you. We’d therefore love to hear your suggestions for future podcast guests, ecosystem builders, or deep tech themes. Feel free to share in a private message or leave a comment below 🙏🏼 (It's also ok to invite yourself 😉) Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    E66 #Ecosystem Builders "From excellent research to real-world impact" with Jens Nielsen

  8. 3 Jun

    E65 #Ecosystem Builders "Bridging Innovation: From Academia to Life Science Startups" with Søren Spanner Bach & Per Christensen

    In this miniseries episode of Life Science Talent Talks, hosted by Soren in collaboration with Black Swans Exist, we explore how scientific innovation moves from universities and research hubs into real-world companies. Soren and Per Christensen (co-founder of Black Swans Exist) discuss the “bridge” between academia and industry - where great ideas are created, but not always scaled - and why talent, execution, and cross-sector collaboration are key to turning research into impactful solutions. The conversation also touches on Europe’s innovation challenges, the startup ecosystem, and the need for more entrepreneurial courage in science and academia. Timestamps 00:30 – Meet Per Christensen & his background01:00 – Purpose of the mini-series: bridging innovation and execution01:14 – What Black Swans Exist does in the ecosystem02:15 – The “bridge” between academia and real-world application02:50 – Gaps in innovation vs. execution03:00 – Untapped innovation potential within universities03:35 – Talent, funding, and enabling innovation04:00 – Why this podcast exists04:19 – Importance of ecosystem builders & shared perspectives04:30 – Inspiring entrepreneurship and showcasing role models05:15 – Breaking silos & sharing actionable learnings05:42 – What to expect from the conversations in this series06:00 – Entrepreneurial mindset in academia06:24 – Innovation and the future economy06:51 – Are we doing enough in innovation?07:00 – Europe’s strengths vs. commercialization challenges07:44 – Regulation vs. innovation discussion08:00 – Driving societal change & the need for innovators08:39 – Closing remarks Key Takeaways Innovation often exists in universities - but scaling it requires the right people and structuresTalent acquisition is a critical bottleneck in life science and deep tech startupsEurope has strong research output but struggles with commercialization and executionCross-sector collaboration can unlock faster innovationInspiration and role models can encourage more people to start companiesBridging academia and industry is essential for future economic growth Notable Quotes “If we inspire just one person to start a company, it’s a success.” “We need innovators and brave people willing to take risks.” Call to Action If this episode sparked your interest: Share it with someone working in science, startups, or innovation Follow the miniseries for more conversations with ecosystem builders

    E65 #Ecosystem Builders "Bridging Innovation: From Academia to Life Science Startups" with Søren Spanner Bach & Per Christensen
See All (73)

About

We want to build a community to inspire life science professionals and leaders through talent talks and organized events. Share knowledge across the life science community through personal stories of their journey. 𝗕𝗲𝗰𝗼𝗺𝗲 𝗽𝗮𝗿𝘁 𝗼𝗳 𝘁𝗵𝗲 𝗟𝗶𝗳𝗲 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗧𝗮𝗹𝗲𝗻𝘁 𝗘𝗰𝗼𝘀𝘆𝘀𝘁𝗲𝗺: Take part in shaping this community by sharing your feedback, questions or ideas. This you can do through our community page: https://www.linkedin.com/groups/12717528/ Follow us: Nehar: https://www.linkedin.com/in/neharmortuza/ and Søren: https://www.linkedin.com/in/soren-spanner-bach/

Information

  • Creator
    Life Science Talent Ecosystem
  • Years Active
    2023 - 2026
  • Episodes
    73
  • Rating
    Clean
  • Copyright
    © Life Science Talent Ecosystem
  • Show Website
    Life Science Talent Talks